Legal Opinion
Bartlett v. Mutual Pharmaceutical Co., Inc.
Court of Appeals for the First Circuit
Decided May 2, 2012No. 10-2277PublishedCited by 22 opinions
1Opinion of the Court
BOUDIN, Circuit Judge.
This products liability case arises out of severe and permanent injuries sustained by plaintiff Karen Bartlett after taking sulindac, a generic non-steroidal anti-inflammatory drug (“NSAID”) manufactured by (among others) defendant Mutual Pharmaceutical Company (“Mutual”). Sulindac is known to cause, in rare instances, a hypersensitivity reaction called Stevens-Johnson Syndrome and its more generous cousin toxic epidermal necrolysis (“SJS/TEN”). In December 2004, Bartlett’s doctor prescribed (for her shoulder pain) sulindac under the brand-name Clinoril made by the…
2Cases cited28 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Wyeth v. LevineSupreme Court of the United States · 2009
- State Oil Co. v. KhanSupreme Court of the United States · 1997
- Riegel v. Medtronic, Inc.Supreme Court of the United States · 2008
- PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
23 more not listed; retrieve them via the Exa API.
3Cited by22 opinions
- Mut. Pharm. Co. v. BartlettSupreme Court of the United States · 2013
- Eleanor Fulgenzi v. PLIVA, Inc.Court of Appeals for the Sixth Circuit · 2013
- Mutual Pharmaceutical Co. v. BartlettSupreme Court of the United States · 2013
- Shirley Bell v. PfizerCourt of Appeals for the Eighth Circuit · 2013
- Morris v. PLIVA, Inc.Court of Appeals for the Fifth Circuit · 2013
17 more not listed; retrieve them via the Exa API.